非急性肾衰为主症的连续性肾脏替代疗法临床应用
作者：徐 虹 (综述) 叶朝阳 (审校)
单位：徐 虹 (综述) 叶朝阳 (审校) 第二军医大学附属长征医院肾内科，上海 200003
关键词：
New Page 1 [1]Davenport A, Will EJ, Davidson AM. Imporved cardiovascular stability during continuous modes ofrenal replacement theray in critically ill patients with acute hepatic and renal failure. Crit Crae Med, 1993,21:328.
[2]Heidekmann SM, Ofenstein JP, Sarnaik AP. Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock, 1994,44:183.
, 百拇医药
[3]Rogiers P,Zhang H, Smail N, et al. High-volume hemofiltration improves hemodnamics in experimental endotoxic shock. Intensive Care Med, 1996,22:S396.
[4] Hoffmann JN, Hartl WH, Deppisch R, et al. Hemofiltration in huaman sepsis: Evidence for eliminstion of immunomodulatory substances. Kidney Intern, 1995,48:1563.
[5]Sato T, Orlowski KP, Zborowski M. Experimental study of extracorporeal perfusion for septic shock. ASAIO J, 1993,39:M790.
, 百拇医药
[6]Canaud B, Leray-Moragues H, Garred LJ, et al. Slow isolated ultrafiltration for the treatment of congestive heart failure. Am J Kidney Dis, 1996,28:S67.
[7]Nicolau DP, feng YJ, WU AHB, et al. Evaluation of myoglobin clearance during continuous hemofiltration in aswine model of acute renal failure. Int J Artif Organs, 1996,19:578.
[8]Winterberg B, Ramme K, Tenschert W, et al. Hemofiltration in myoglobinutic acute renal failure. Int j Artif Organs, 1990,13:113.
, 百拇医药
[9]Berns JS, Cohen RM, Rudnick MR. Removal of myoglobin by CAVH-D intraumatic rhabdomyolysis. Am J Nephrol, 1991,11:73.
[10]Bellomo R, Daskalakis M, Parkin G, et al. Myoglobin clearance during acute continuous hemodiafiltration. Intensive Care Med, 1991,17:509.
[11]季大玺，谢红浪，刘芸，等.连续性肾脏替代治疗在重症急性肾功能衰竭救中的应用.肾脏病与透析肾移植杂志，1997，6：415.
[12]Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in patients during continuous renal replacement therapy. Clin Pharmacokinet, 1993,24:362.
, 百拇医药
[13]Bellomo R, Mansfield D, Rumble S, et al. A comparison of conventional dialytic therapy and acute continuous hemodiafiltration in the management of acute renal failure in the critically Ⅲ. Renal Failure, 1993,15:595.
[14]Davenport A, Will FJ, Davison AM. Hyperlactatemia and metanolic axidosis during hemofiltration using lactate buffered fluids. Nehron, 1991,59:461.
[15]Schiffl H, Lang SM, Kinig A, et al. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet, 1994,344:570.
[16]Lauer A, Alvis R, Avram M. hemodynamic consequences of continuous arterovenous hemofiltration. Am J kidney Dis, 1998,12:110.
收稿：1999-03-02
修回：1999-07-13, 百拇医药
单位：徐 虹 (综述) 叶朝阳 (审校) 第二军医大学附属长征医院肾内科，上海 200003
关键词：
New Page 1 [1]Davenport A, Will EJ, Davidson AM. Imporved cardiovascular stability during continuous modes ofrenal replacement theray in critically ill patients with acute hepatic and renal failure. Crit Crae Med, 1993,21:328.
[2]Heidekmann SM, Ofenstein JP, Sarnaik AP. Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock, 1994,44:183.
, 百拇医药
[3]Rogiers P,Zhang H, Smail N, et al. High-volume hemofiltration improves hemodnamics in experimental endotoxic shock. Intensive Care Med, 1996,22:S396.
[4] Hoffmann JN, Hartl WH, Deppisch R, et al. Hemofiltration in huaman sepsis: Evidence for eliminstion of immunomodulatory substances. Kidney Intern, 1995,48:1563.
[5]Sato T, Orlowski KP, Zborowski M. Experimental study of extracorporeal perfusion for septic shock. ASAIO J, 1993,39:M790.
, 百拇医药
[6]Canaud B, Leray-Moragues H, Garred LJ, et al. Slow isolated ultrafiltration for the treatment of congestive heart failure. Am J Kidney Dis, 1996,28:S67.
[7]Nicolau DP, feng YJ, WU AHB, et al. Evaluation of myoglobin clearance during continuous hemofiltration in aswine model of acute renal failure. Int J Artif Organs, 1996,19:578.
[8]Winterberg B, Ramme K, Tenschert W, et al. Hemofiltration in myoglobinutic acute renal failure. Int j Artif Organs, 1990,13:113.
, 百拇医药
[9]Berns JS, Cohen RM, Rudnick MR. Removal of myoglobin by CAVH-D intraumatic rhabdomyolysis. Am J Nephrol, 1991,11:73.
[10]Bellomo R, Daskalakis M, Parkin G, et al. Myoglobin clearance during acute continuous hemodiafiltration. Intensive Care Med, 1991,17:509.
[11]季大玺，谢红浪，刘芸，等.连续性肾脏替代治疗在重症急性肾功能衰竭救中的应用.肾脏病与透析肾移植杂志，1997，6：415.
[12]Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in patients during continuous renal replacement therapy. Clin Pharmacokinet, 1993,24:362.
, 百拇医药
[13]Bellomo R, Mansfield D, Rumble S, et al. A comparison of conventional dialytic therapy and acute continuous hemodiafiltration in the management of acute renal failure in the critically Ⅲ. Renal Failure, 1993,15:595.
[14]Davenport A, Will FJ, Davison AM. Hyperlactatemia and metanolic axidosis during hemofiltration using lactate buffered fluids. Nehron, 1991,59:461.
[15]Schiffl H, Lang SM, Kinig A, et al. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet, 1994,344:570.
[16]Lauer A, Alvis R, Avram M. hemodynamic consequences of continuous arterovenous hemofiltration. Am J kidney Dis, 1998,12:110.
收稿：1999-03-02
修回：1999-07-13, 百拇医药